Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of amiloride and spironolactone on renal and cardiovascular parameters in healthy subjects
2008-003336-38Phase 4Completed
- Sponsor
- Department of Medical Research
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amiloride and spironolactone in hypertension (HTN) (3 arms), sponsored by Department of Medical Research. Primary endpoints: Renal function parameters and Blood pressure. Started Sep 2008; status: completed.
02
Drugs
amiloridespironolactone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2008-003336-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003336-38.